Diabetes

Serum marker predicts cardiovascular events in diabetes

(HealthDay)—Elevated levels of polyclonal serum immunoglobulin combined free light chains (cFLCs) may indicate adverse cardiovascular disease (CVD) outcomes in patients with type 2 diabetes, according to research published ...

Oncology & Cancer

Metformin use doesn't cut incidence of bladder cancer

(HealthDay)—For patients with type 2 diabetes, metformin use is not associated with a significantly reduced risk of bladder cancer, according to a study published online Feb. 4 in Diabetes Care.

Surgery

Shedding new light on double-lung transplants

In the largest retrospective study to date using data from the United Network for Organ Sharing (UNOS) database for adult double-lung transplants, Temple University School of Medicine researchers have shown that there is ...

Diabetes

Diabetic peripheral neuropathy prevalent in youth with T2DM

(HealthDay)—The prevalence of diabetic peripheral neuropathy (DPN) is 25.7 percent among youth with type 2 diabetes, and is significantly higher than that seen among youth with type 1 diabetes, according to a study published ...

Diabetes

Researchers identify novel biomarker for diabetes risk

Researchers at the Vanderbilt Heart and Vascular Institute and Massachusetts General Hospital have identified a biomarker that can predict diabetes risk up to 10 years before onset of the disease.

Diabetes

Severe hypoglycemia in diabetes tied to cardiac disease

(HealthDay)—For patients with type 1 and type 2 diabetes, severe hypoglycemia is associated with severe hypertension, hypokalemia, and QT prolongation, according to a study published online Aug. 12 in Diabetes Care.

page 5 from 10